Literature DB >> 25091978

Focal dysplasia of the cerebral cortex and infantile spasms associated with somatic 1q21.1-q44 duplication including the AKT3 gene.

V Conti1, M Pantaleo2, C Barba1, G Baroni3, D Mei1, A M Buccoliero4, S Giglio2, F Giordano5, S T Baek6, J G Gleeson6, R Guerrini1,7.   

Abstract

Somatic and germline duplications or activating mutations of AKT3 have been reported in patients with hemimegalencephaly and megalencephaly. We performed array comparative genomic hybridization on brain tissue and blood in 16 consecutive patients with symptomatic epilepsy due to focal or multilobar malformations of cortical development who underwent surgical treatment of epilepsy. One patient with infantile spasms and a dysplastic left frontal lobe harboured a somatic trisomy of the 1q21.1-q44 chromosomal region, encompassing the AKT3 gene, in the dysplastic brain tissue but not in blood and saliva. Histopathology revealed severe cortical dyslamination, a thin cortex in the premotor area with microgyri and microsulci, immature neurons with disoriented dendrites and areas of cortical heterotopia in the sub-cortical white matter. These cytoarchitectural changes are close to those defining type Ib focal cortical dysplasia. Immunohistochemistry in brain specimens showed hyperactivation of the PI3K/AKT/mTOR pathway. These findings indicate that AKT3 upregulation may cause focal malformations of cortical development. There appears to be an etiologic continuum between hemimegalencephaly and focal cortical dysplastic lesions. The extent of brain malformations due to AKT3 upregulation may be related to the embryonic stage when the post-zygotic gene alteration occurs.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  AKT3 duplication; focal cortical dysplasia; mTOR pathway; nodular heterotopia

Mesh:

Substances:

Year:  2014        PMID: 25091978     DOI: 10.1111/cge.12476

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  23 in total

1.  Activation of extracellular regulated kinase and mechanistic target of rapamycin pathway in focal cortical dysplasia.

Authors:  Vinit V Patil; Miguel Guzman; Angela N Carter; Geetanjali Rathore; Daniel Yoshor; Daniel Curry; Angus Wilfong; Satish Agadi; John W Swann; Adekunle M Adesina; Meenakshi B Bhattacharjee; Anne E Anderson
Journal:  Neuropathology       Date:  2015-09-18       Impact factor: 1.906

2.  PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia.

Authors:  Laura A Jansen; Ghayda M Mirzaa; Gisele E Ishak; Brian J O'Roak; Joseph B Hiatt; William H Roden; Sonya A Gunter; Susan L Christian; Sarah Collins; Carissa Adams; Jean-Baptiste Rivière; Judith St-Onge; Jeffrey G Ojemann; Jay Shendure; Robert F Hevner; William B Dobyns
Journal:  Brain       Date:  2015-02-25       Impact factor: 13.501

3.  Malformations of Cerebral Cortex Development: Molecules and Mechanisms.

Authors:  Gordana Juric-Sekhar; Robert F Hevner
Journal:  Annu Rev Pathol       Date:  2019-01-24       Impact factor: 23.472

4.  Somatic SLC35A2 variants in the brain are associated with intractable neocortical epilepsy.

Authors:  Melodie R Winawer; Nicole G Griffin; Jorge Samanamud; Evan H Baugh; Dinesh Rathakrishnan; Senthilmurugan Ramalingam; David Zagzag; Catherine A Schevon; Patricia Dugan; Manu Hegde; Sameer A Sheth; Guy M McKhann; Werner K Doyle; Gerald A Grant; Brenda E Porter; Mohamad A Mikati; Carrie R Muh; Colin D Malone; Ann Marie R Bergin; Jurriaan M Peters; Danielle K McBrian; Alison M Pack; Cigdem I Akman; Christopher M LaCoursiere; Katherine M Keever; Joseph R Madsen; Edward Yang; Hart G W Lidov; Catherine Shain; Andrew S Allen; Peter D Canoll; Peter B Crino; Annapurna H Poduri; Erin L Heinzen
Journal:  Ann Neurol       Date:  2018-05-16       Impact factor: 10.422

5.  Ultra-High-Field Targeted Imaging of Focal Cortical Dysplasia: The Intracortical Black Line Sign in Type IIb.

Authors:  E Bartolini; M Cosottini; M Costagli; C Barba; L Tassi; R Spreafico; R Garbelli; L Biagi; A Buccoliero; F Giordano; R Guerrini
Journal:  AJNR Am J Neuroradiol       Date:  2019-11-14       Impact factor: 3.825

6.  Genetic heterogeneity in infantile spasms.

Authors:  Alison M Muir; Candace T Myers; Nancy T Nguyen; Julia Saykally; Dana Craiu; Peter De Jonghe; Ingo Helbig; Dorota Hoffman-Zacharska; Renzo Guerrini; Anna-Elina Lehesjoki; Carla Marini; Rikke S Møller; Jose Serratosa; Katalin Štěrbová; Pasquale Striano; Sarah von Spiczak; Sarah Weckhuysen; Heather C Mefford
Journal:  Epilepsy Res       Date:  2019-07-29       Impact factor: 3.045

7.  Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia.

Authors:  Alissa M D'Gama; Ying Geng; Javier A Couto; Beth Martin; Evan A Boyle; Christopher M LaCoursiere; Amer Hossain; Nicole E Hatem; Brenda J Barry; David J Kwiatkowski; Harry V Vinters; A James Barkovich; Jay Shendure; Gary W Mathern; Christopher A Walsh; Annapurna Poduri
Journal:  Ann Neurol       Date:  2015-02-26       Impact factor: 10.422

Review 8.  Genetic Basis of Brain Malformations.

Authors:  Elena Parrini; Valerio Conti; William B Dobyns; Renzo Guerrini
Journal:  Mol Syndromol       Date:  2016-08-27

9.  2014 Epilepsy Benchmarks Area I: Understanding the Causes of the Epilepsies and Epilepsy-Related Neurologic, Psychiatric, and Somatic Conditions.

Authors:  Rochelle Caplan; Heather Mefford; Madison Berl; Bernard Chang; Jack Lin; Andrey Mazarati; Brandy Fureman; Ray Dingledine
Journal:  Epilepsy Curr       Date:  2016 May-Jun       Impact factor: 7.500

10.  Mutations of AKT3 are associated with a wide spectrum of developmental disorders including extreme megalencephaly.

Authors:  Diana Alcantara; Andrew E Timms; Karen Gripp; Laura Baker; Kaylee Park; Sarah Collins; Chi Cheng; Fiona Stewart; Sarju G Mehta; Anand Saggar; László Sztriha; Melinda Zombor; Oana Caluseriu; Ronit Mesterman; Margot I Van Allen; Adeline Jacquinet; Sofia Ygberg; Jonathan A Bernstein; Aaron M Wenger; Harendra Guturu; Gill Bejerano; Natalia Gomez-Ospina; Anna Lehman; Enrico Alfei; Chiara Pantaleoni; Valerio Conti; Renzo Guerrini; Ute Moog; John M Graham; Robert Hevner; William B Dobyns; Mark O'Driscoll; Ghayda M Mirzaa
Journal:  Brain       Date:  2017-10-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.